虽然目前仍无法确定原发病灶与脑转移病灶Ki-67指数的变化是否与患者的生存期有关,但这为今后的研究提供了方向。 参考文献: [1] Chen JX; Zhou JM; Zhang HQ, et al. Conversion of ER, PR, HER2 and Ki-67 and Prognosis ...
虽然目前仍无法确定原发病灶与脑转移病灶Ki-67指数的变化是否与患者的生存期有关,但这为今后的研究提供了方向。 参考文献: [1] Chen JX; Zhou JM; Zhang HQ, et al. Conversion of ER, PR, HER2 and Ki-67 and Prognosis in breast cancer metastases to the brain. 10.21203/rs.3.rs-1692389/v1. *...
Ki-67 is a nuclear protein and a proliferation marker frequently used in establishing the prognosis for breast cancer patients. To investigate the prognostic value of the Ki-67 proliferation index in female cats with mammary carcinoma, a prospective study was conducted with 96 ani...
The proliferation marker Ki-67 is one of the most controversially discussed parameters for treatment decisions in breast cancer patients. The purpose of th
虽然目前仍无法确定原发病灶与脑转移病灶Ki-67指数的变化是否与患者的生存期有关,但这为今后的研究提供了方向。 参考文献 Chen JX; Zhou JM; Zhang HQ, et al. Conversion of ER, PR, HER2 and Ki-67 and Prognosis in breast cancer metastases to the brain. 10.21203/rs.3.rs-1692389/v1....
Ann Surg 245: 707–716 Ki-67 expression is associated with poor prognosis in early-stage breast cancer Ki-67 is a proliferation marker that has been used to evaluate the response to chemo therapy in early-stage breast cancer. Various studies have suggested that this protein might have ...
Table 1 Characteristics of the 1800 triple-negative breast cancer patients. Full size table . Cutoff value for Ki-67 verified in the PSM cohort To define the most relevant cutoff value for Ki-67 distinguishing prognosis, we used the online tool “Cutoff Finder”. This method has been employed...
Introduction Ki-67 expression is a biomarker for proliferation. Its prognostic value is recognized in breast cancer (BC) patients with negative axillary nodes, but is less clear in BC patients with positive axillary lymph nodes. Metho
Furthermore, the prognosis prediction potential of Ki-67 was correlated to that of the conventional clinicopathological factors in multivariate analysis. Methods A total of 120 patients diagnosed with invasive breast cancer and treated with NAC at Semmelweis University in Hungary between 2002 and 2013 ...
Is Ki-67 Really Useful as a Predictor for Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer? Article 29 September 2023 Ki-67 and breast cancer prognosis: does it matter if Ki-67 level is examined using preoperative biopsy or postoperative specimen? Article Open access 13...